Orchid Pharma fundamental analysis

ORCHPHARMA

663.9

0.55 (-0.08%)
Last updated on 16 Feb, 2026 | 15:31 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Orchid Pharma Fundamentals

P/E Ratio

178.63

P/B Ratio

2.67

Div. Yield

0

Sector P/E

65.34

Sector P/B

2.77

Sec. Div. Yield

0.57

Orchid Pharma Fundamentals is currently trading with a P/E Ratio of 178.63, compared to the sector average of 65.34. Its P/B Ratio stands at 2.67, while the sector’s is 2.77. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.57%.

Orchid Pharma Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Good

  • quality_check
    Quality

    Poor

  • quality_check
    Management

    Poor

On its scorecard, Orchid Pharma reflects: Price – Expensive, Growth – Good, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.